
Inhibikase Therapeutics, Inc.
Inhibikase Therapeutics, Inc. (IKT)
WebsitePrice
Market cap
Next catalystExpected 1H 2027IKT-001 — IMPROVE-PAH · Phase 3 dataCompany release ↗
Cash
Chart & Events
Core Clinical
Technology Summary
Scientific context
Detailed technology interpretation
Technology advantages
Representative pipeline applications
Clinical
Upcoming clinical milestones
Other pipelines
PreINDP1P2FilingApproved